TARRYTOWN, N.Y.--(BUSINESS WIRE)--Feb. 8, 2016--
Prestige Brands Holdings, Inc. (NYSE:PBH) (“Prestige”) today announced
that it has closed the previously announced acquisition of DenTek
Holdings, Inc (“DenTek”), a privately-held marketer and distributor of
specialty oral care products.
The closing was finalized pursuant to the terms of the merger agreement,
announced on November 23, 2015, under which Prestige agreed to acquire
DenTek from its stockholders, including TSG Consumer Partners, for a
purchase price of $225 million. The acquisition will expand Prestige’s
portfolio of iconic brands, strengthen its existing oral care platform
and increase its geographic reach in parts of Europe.
The Company financed the transaction with a combination of available
cash on hand, available cash from its Asset Based Loan (“ABL”) revolver,
and a recently completed financing of an additional unsecured bridge
loan.
About Prestige Brands
The Company markets and distributes brand name over-the-counter and
household cleaning products throughout the U.S. and Canada, Australia,
and in certain international markets. Core brands include Monistat®
women’s health products, Nix® lice treatment, Chloraseptic® sore throat
treatments, Clear Eyes® eye care products, Compound W® wart treatments,
The Doctor's® NightGuard® dental protector, Little Remedies® pediatric
over-the-counter products, Efferdent® denture care products, Luden's®
throat drops, Dramamine® motion sickness treatment, BC® and Goody's®
pain relievers, Beano® gas prevention, Debrox® earwax remover, and
Gaviscon® antacid in Canada. Visit the Company's website at
www.prestigebrands.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160208006319/en/
Source: Prestige Brands Holdings, Inc.
Prestige Brands Holdings, Inc.
Dean Siegal, 914-524-6819
